Neuroreport · 2001 · 138 citations · 9 references
Life SciencesNeurologyNeuroscienceAgingCognitive NeuroscienceNeurochemistryAlzheimer DiseaseCognitive AgingCognitive ImpairmentMagnetic Resonance SpectroscopyNeurodegenerative DiseasesNeurodegenerative Disorders1D Proton Nuclear Magnetic Resonance SpectroscopyAge-related Brain ChangesCholine MetabolismMagnetic ResonanceMild Cognitive Impairment DiagnosisNuclear Magnetic Resonance SpectroscopyWhite Matter AbnormalitiesWhite Matter Aging
This study aimed to characterize the white matter biochemical profile of healthy elderly subjects, mild cognitive impairment (MCI) subjects, and early Alzheimer's disease (AD) patients. We used proton magnetic resonance spectroscopy ((1)H-MRS) to measure myo-inositol, creatine, N-acetylaspartate (NAA) and choline levels from a volume of interest located in the paratrigonal white matter bilaterally. A significantly higher myo-inositol/creatine ratio was found in MCI subjects and AD patients than in controls. The NAA/creatine ratio was reduced in AD patients in the left hemisphere compared to control subjects. The choline/creatine ratio was not significantly different among the three groups. These data suggest that MCI is different from normal brain aging, having a white matter biochemical pattern similar to AD.
9
Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al. · Archives of Neurology · 1999 · 9K citations
Medicine, Neurology, Psychiatry +17
Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease
Kejal Kantarci, Clifford R. Jack, Yun Xu et al. · Neurology · 2000 · 466 citations · Full text
Mild cognitive impairment: conceptual basis and current nosological status
Karen Ritchie, Jacques Touchon · The Lancet · 2000 · 393 citations
Medicine, Neurology, Psychiatry +16
Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.
B L Miller, Rex Moats, Truda Shonk et al. · Radiology · 1993 · 363 citations